OrbiMed Debuts $222M Israeli Life Sciences Venture Fund
Investment management firm OrbiMed Advisors LLC on Monday launched a $222 million venture capital fund aimed at beefing up its portfolio with Israeli life sciences companies in a sector fund managers...To view the full article, register now.
Already a subscriber? Click here to view full article